bladder cancer characteristically causes blood in the urine , which may be visible or detectable only by microscope blood in the urine is the most common symptom in bladder cancer , and is painless visible blood in the urine may be of only short duration , and a urine test may be required to confirm non-visible blood between 80 and 90 % of people with bladder cancer initially presented with visible blood other possible symptoms include dysuria , frequent urination , or feeling the need to urinate without being able to do so these signs and symptoms are not specific to bladder cancer , and may also be caused by non-cancerous conditions , including prostate infections , overactive bladder or cystitis some rare forms of bladder cancer like urachal cancer produce mucin , which is then excreted in the urine causing it to be thick there is an almost linear relationship between smoking duration ( in years ) , pack-year and bladder cancer risk risk of bladder cancer decreases by 30 % within 1–4 years and continues to decrease by 60 % at 25 years after smoking cessation opium consumption increases the risk of bladder cancer by 3-fold and concurrent use of opium and smoking increases the risk of bladder cancer by 5 times compared to the general population thirty percent of bladder tumors probably result from occupational exposure in the workplace to carcinogens infection with schistosoma haematobium ( bilharzia or schistosomiasis ) may cause bladder cancer , specially of the squamous cell type n-nitroso compounds have been implicated in the pathogenesis of schistosomiasis related bladder cancer other causes of squamous cell carcinoma of the bladder include chronic catheterizations in people with a spinal cord injury and history of treatment with cyclophosphamide people who undergo external beam radiotherapy ( ebrt ) for prostate cancer have a higher risk of developing invasive bladder cancer 10–20 % risk increase ) associated with bladder cancer , for example , obesity mutations in fgfr3 , tp53 , pik3ca , kdm6a , arid1a , kmt2d , hras , tert , kras , crebbp , rb1 and tsc1 genes may be associated with some cases of bladder cancer deletions of parts or whole of chromosome 9 is common in bladder cancer similarly , mutations in nat2 ( n-acetyltransferase ) is associated with increased risk for bladder cancer various single-nucleotide polymorphisms in psca gene present on chromosome 8 have shown to increase the risk for bladder cancer globally , in 2017 , bladder cancer resulted in 196,000 deaths , a 5.4 % ( age adjusted ) decrease from 2007 bladder cancer is the sixth most common cancer accounting for 3.7 % of the new cancer cases bladder cancer is the ninth most common cancer in the uk accounting for 2.7 % of all the new cancers cases bladder cancer is the fourth most common type of cancer in men and the 12th most common cancer in women 